Tarsus Pharmaceuticals, Inc. (TARS) short interest & options flow
NASDAQTarsus Pharmaceuticals carries a relatively light short position compared with several of its closest Nasdaq peers heading into Thursday's earnings release. Short interest at 13.9% of free float is meaningful, but ARVN and HRMY both declined sharply last week (down 4.8% and 2.5% respectively), while TARS gained 2.7%, suggesting the stock is not trading in…
- Market cap
- $3.19B
- Next earnings
- 6 Nov 2026
Key data as of 4 Nov 2026

TARS news and analysis
RSSNo long-form analysis yet for TARS. Pulse alerts and the live data picture are available on ORTEX.
Open TARS on ORTEX →Want the live picture for TARS?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TARS — free to start on ORTEX.
Sign up for free →Open TARS on ORTEX